We are extremely excited and thankful to the American Cancer Society and the Harper Cancer Research Institute for facilitating this seed grant for our work on label-free targeting of undruggable cancer cells. We intend to target non-targetable cancer cells by tuning the force exerted by label-free nanomaterials at the cell membrane to selectively permeabilize the …
Category Archive: chemotherapeutics
Feb 14
American Cancer Society Seed Grant Awarded to us to Develop a Label-Free, Precise Chemotherapeutic Delivery to Metastatic Breast Cancer Cells In Vivo
Categories:
AD&T Notre Dame, American Cancer Society, Berthiaume Institute for Precision Health, chemotherapeutics, Harper Cancer Research Institute, Label-free, magnetoelectrics, metastatic cancer cells
by Prakash
Tags: NDNano
Recent Posts
- Celebrating Excellence: Kendall Bradley Shines at NIRSEF 2026! March 4, 2026
- Invited Talk at the Innovation Sciences Seminar Series hosted at Rosalind Franklin University of Medicine and Science February 12, 2026
- Our Lab at Notre Dame Receives Notice of Patent Allowance for Novel Nanoparticle Immunotherapy Technology January 19, 2026
- 2025 in Review: Innovation, Funding, and Student Success December 9, 2025
- Precision Chemotherapy: Externally Controlled Nanocarriers for Aggressive Cancers December 6, 2025
Archives
Categories
NIH Funding Opportunities
- Notice of NICHD Participation in PAR-24-204 "Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)" March 27, 2026Notice NOT-HD-26-004 from the NIH Guide for Grants and Contracts
- Harmonizing the NIH Definition of Intervention with the Common Rule March 27, 2026Notice NOT-OD-26-063 from the NIH Guide for Grants and Contracts
- Notice of NHLBI Participation in PA-25-304 "NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)" March 26, 2026Notice NOT-HL-26-003 from the NIH Guide for Grants and Contracts
- Notice to Rescind NOT-HL-23-070 "NHLBI Supplement to the NIH Policy for Data Management and Sharing" March 26, 2026Notice NOT-HL-26-004 from the NIH Guide for Grants and Contracts
- Draft NIH Resources to Support Implantable Device Trials March 25, 2026Notice NOT-OD-26-061 from the NIH Guide for Grants and Contracts
- Publication of the Revised NIH Grants Policy Statement (Rev. March 2026) for Fiscal Year 2026 March 25, 2026Notice NOT-OD-26-057 from the NIH Guide for Grants and Contracts
- Notice of National Cancer Institutes Participation in PA-25-305, NIH Research Project Grant (Parent R01 Clinical Trial Required) March 25, 2026Notice NOT-CA-26-009 from the NIH Guide for Grants and Contracts
- Prior Approval Requirement for Changes to Domestic Subawards March 25, 2026Notice NOT-OD-26-062 from the NIH Guide for Grants and Contracts
- Notice of Participation of the National Center for Advancing Translational Sciences (NCATS) in PA-24-201, Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) March 24, 2026Notice NOT-TR-26-008 from the NIH Guide for Grants and Contracts

Recent Comments